TEVA
Teva Pharmaceutical Industries Ltd Earnings
$30.34
Earnings Summary
Revenue | $4480Mn |
Net Profits | $433Mn |
Net Profit Margins | 9.67% |
Teva Pharmaceutical Industries Ltd’s revenue jumped 3.44% since last year same period to $4480Mn in the Q3 2025. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated 7.28% jump in its revenue since last 3-months.
Teva Pharmaceutical Industries Ltd’s net profit jumped 199.08% since last year same period to $433Mn in the Q3 2025. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated 53.55% jump in its net profits since last 3-months.
Teva Pharmaceutical Industries Ltd’s net profit margin jumped 195.79% since last year same period to 9.67% in the Q3 2025. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated 43.13% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 0.67 |
EPS Estimate Current Year | 0.67 |
Teva Pharmaceutical Industries Ltd’s earning per share (EPS) estimates for the current quarter stand at 0.67 - a 8.06% jump from last quarter’s estimates.
Teva Pharmaceutical Industries Ltd’s earning per share (EPS) estimates for the current year stand at 0.67.
Key Ratios
Earning Per Share (EPS) | 0.78 |
Teva Pharmaceutical Industries Ltd’s earning per share (EPS) jumped 300% since last year same period to 0.78 in the Q3 2025. This indicates that the Teva Pharmaceutical Industries Ltd has generated 300% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-11-05 | 0.67 | 0.78 | 16.42% |
2025-07-30 | 0.62 | 0.66 | 6.45% |
2025-05-07 | 0.46 | 0.52 | 13.04% |
